This cohort study examines nationwide registry data for Swedish residents with a diagnosis of alcohol use disorder to determine whether hospitalization risk for an individual is decreased during periods of GLP-1 agonist use vs periods of nonuse. This evidence concerns the gene GLP1R and alcohol abuse.